PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.23%
Negative revenue growth while 2127.T stands at 55.32%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
4.03%
Gross profit growth under 50% of 2127.T's 129.98%. Michael Burry would be concerned about a severe competitive disadvantage.
16.71%
EBIT growth below 50% of 2127.T's 217.62%. Michael Burry would suspect deeper competitive or cost structure issues.
10.30%
Operating income growth under 50% of 2127.T's 250.62%. Michael Burry would be concerned about deeper cost or sales issues.
4.09%
Net income growth under 50% of 2127.T's 173.03%. Michael Burry would suspect the firm is falling well behind a key competitor.
4.08%
EPS growth under 50% of 2127.T's 172.87%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
4.08%
Diluted EPS growth under 50% of 2127.T's 168.88%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Share reduction while 2127.T is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 2127.T is at 1.48%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Dividend reduction while 2127.T stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.09%
10Y revenue/share CAGR under 50% of 2127.T's 1140.20%. Michael Burry would suspect a lasting competitive disadvantage.
71.44%
5Y revenue/share CAGR under 50% of 2127.T's 157.23%. Michael Burry would suspect a significant competitive gap or product weakness.
36.36%
3Y revenue/share CAGR similar to 2127.T's 36.33%. Walter Schloss would assume both companies experience comparable short-term cycles.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
155.81%
Below 50% of 2127.T's 2386.34%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
122.26%
5Y net income/share CAGR at 50-75% of 2127.T's 171.46%. Martin Whitman might see a shortfall in operational efficiency or brand power.
61.49%
3Y net income/share CAGR above 1.5x 2127.T's 21.38%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
198.97%
Below 50% of 2127.T's 638.71%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
124.19%
5Y equity/share CAGR at 75-90% of 2127.T's 160.14%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
57.00%
3Y equity/share CAGR at 50-75% of 2127.T's 107.25%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-100.00%
Cut dividends over 10 years while 2127.T stands at 1340.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.00%
Firm’s AR is declining while 2127.T shows 98.97%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.29%
Inventory shrinking or stable vs. 2127.T's 84.87%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-1.54%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
4.33%
1.25-1.5x 2127.T's 2.97%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-44.81%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
89.49%
SG&A growth well above 2127.T's 4.04%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.